Endocrine 2 (Type 2 Diabetes | Cardio Risk ) Flashcards
What is Type 2 Diabetes
Insulin Resistance
Hyperinsulinemia
Hyperglycemia
- Later stages beta-cell destruction
Type 1 vs Type 2 Diabetes
Type 1 can be treated with insulin therapy
Type 2 can only be treated with insulin therapy at later stages
Methods to lower glucose in Type 2 Diabetes
Overcome Insulin Resistance
Insulin Independent Methods of Glucose-Lowering
Overcome Insulin Resistance
- Methods?
- Insulin Secretagogues
- Thiazolidinedione
- Metformin?
Insulin Independent Methods of Glucose-Lowering
- Methods?
Decrease Hepatic Glucose Production
- Metformin
Prevent Dietary Glucose Absorption
- Alpha-Glucosidase Inhibitors
Secretagogues
- Examples
1st Generation Sulfonylureas
- Tolbutamide, Chlorpropamide, Acetohexamide
2nd Generation Sulfonylureas
- Glyburide, Glipizide, Glimepiride
Secretagogues
- 1st vs 2nd Generation
2nd Generation Sulfonylureas:
- More potent
- Shorter half life
- Fewer side effects
Less dose needed to get insulin secretion
Secretagogues
- MOA
- Sulfonylurea binds the sulfonylurea receptor/subunit of the K(ATP) channel
- Inhibits K(ATP) channel
- Prevents K+ efflux causing depolarization
- Activates Ca2+ channels causing Ca2+ influx
- Exocytosis of insulin from insulin granules
Result: Increased Insulin Secretion to overcome Insulin resistance
Secretagogues
- Adverse Effects
- Hypoglycemia
- Weight Gain
- Cardiovascular Complications (KATP channels are important in preventing ischemic events)
Non-Sulfonylurea Secretagogues
- Example
- Repaglinide
- Nateglinide
Non-Sulfonylurea Secretagogues
- MOA
- Binds to a different site on K(ATP) Channel
- Inhibits K(ATP) channel
- Prevents K+ efflux causing depolarization
- Activates Ca2+ channels causing Ca2+ influx
- Exocytosis of insulin from insulin granules
More selective for beta cell K(ATP) channels than cardiac cell K(ATP) channels
Rapid onset and Short duration
- Lower risk of hypoglycemia
Alpha-Glucosidase Inhibitors
- Examples
- Acarbose
- Miglitol
- Voglibose
Alpha-Glucosidase Inhibitors
- MOA
- Competitive inhibitor of intestinal alpha-glucosidase enzyme.
- Preventing the breakdown disaccharides
- Delays/Decreases absorption of monosaccharides
- Reduces postprandial glucose rise
Result: Preventing dietary glucose absorption, thus, lowering glucose
Alpha-Glucosidase Inhibitors
- Adverse Effects
- Least effective oral antidiabetic drug
- Does not influence insulin = No Hypoglycemia
- Unbroken sugars cause issues GI issues
Thiazolidinediones
- Examples
Rosiglitazone, Pioglitazone, Troglitazone